AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8155034
Drug: Methazolamide (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methazolamide (50 mg twice daily) for 12 weeks
Trial: 6766274
Drug: Amoxicillin, 6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin, 6 gm by mouth every 24 hours
Trial: 30621764
Drug: Calmangafodipir (PP100‐01)
RxNorm normalized name: mangafodipir
DrugBank: Calmangafodipir (DB18398)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calmangafodipir (PP100‐01) co-administered with a 12-h NAC regimen
Trial: 30621764
Drug: NAC treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NAC treatment alone
Trial: 28738857
Drug: Oral HIV
RxNorm normalized name: HIV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral HIV self-test kits (one of five intervention arms)
Trial: 28738857
Drug: Oral HIV
RxNorm normalized name: HIV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral HIV self-test kits with financial incentive (fixed or lottery amount)
Trial: 28738857
Drug: Oral HIV
RxNorm normalized name: HIV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral HIV self-test kits with phone call reminders
Trial: 25994445
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group attending weekly lectures
Trial: 24099350
Drug: Qishe Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Qishe Pill (3.75 g twice a day for 28 days)
Trial: 24099350
Drug: Placebo (3.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (3.75 g twice a day for 28 days)
Trial: 21216583
Drug: Chromium chloride
RxNorm normalized name: Chromium chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chromium chloride 400 μg
Trial: 15117055
Drug: Lutein 10
RxNorm normalized name: lutein 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lutein 10 mg (Group 1)
Trial: 15117055
Drug: Lutein 10
RxNorm normalized name: lutein 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lutein 10 mg/antioxidants/vitamins and minerals broad spectrum supplementation formula (Group 2)
Trial: 11046202
Drug: 5% albumin
RxNorm normalized name: Flexbumin 5% Albumin (Human) Solution for Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% albumin solution
Trial: 11605923
Drug: 6% hetastarch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6% hetastarch solution
Trial: 16923636
Drug: Active rTMS
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active rTMS (10 Hz, 5 daily sessions)
Trial: 15224788
Drug: Sodium sulfacetamide
RxNorm normalized name: sodium sulfacetamide
DrugBank: Sulfacetamide (DB00634)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium sulfacetamide lotion 10%
Trial: 15224788
Drug: Selenium sulfide
RxNorm normalized name: Selenium Sulfide
DrugBank: Selenium Sulfide (DB00971)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Selenium sulfide lotion 2.5%
Trial: 11513054
Drug: Lignocaine 50
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lignocaine 50 mg
Trial: 9267856
Drug: Idebenone 90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Idebenone 90 mg t.i.d.
Trial: 31464558
Drug: Booster CYD‐TDV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster CYD‐TDV dose (Group 1)
Trial: 24330903
Drug: High-dose unilateral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose unilateral brief pulse ECT (1.0 millisecond)
Trial: 21394895
Drug: Arm B
RxNorm normalized name: arm brace
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arm B (rotated drug pairs) in SRG
Trial: 21394895
Drug: Arm B
RxNorm normalized name: arm brace
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arm B (rotated drug pairs) in IRG
Trial: 10356669
Drug: VIP/P-1 (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VIP/P-1 (25 micrograms vasoactive intestinal polypeptide combined with 1.0 mg phentolamine mesylate)
Trial: 10356669
Drug: VIP/P-2 (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VIP/P-2 (25 micrograms vasoactive intestinal polypeptide combined with 2.0 mg phentolamine mesylate)
Trial: 27160892
Drug: Ticagrelor (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticagrelor (180 mg loading dose on day 1 followed by 90 mg twice daily for days 2 through 90)
Trial: 27160892
Drug: Aspirin (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (300 mg on day 1 followed by 100 mg daily for days 2 through 90)
Trial: 22730539
Drug: Gemtuzumab ozogamicin
RxNorm normalized name: Gemtuzumab Ozogamicin
DrugBank: Gemtuzumab ozogamicin (DB00056)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Gemtuzumab ozogamicin (GO) at 5 mg/m², repeated after 3 weeks
Trial: 18520604
Drug: High-dose MDMA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose MDMA (1.6 mg/kg)
Trial: 31375749
Drug: Glucose solution
RxNorm normalized name: TrueControl Glucose Solution Level 0
DrugBank: Dextrose, unspecified form (DB09341)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucose solution with EB
Trial: 31375749
Drug: Glucose solution
RxNorm normalized name: TrueControl Glucose Solution Level 0
DrugBank: Dextrose, unspecified form (DB09341)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glucose solution without EB
Trial: 22384546
Drug: Tongguan Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tongguan Capsule
Trial: 30043582
Drug: Conventional Western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Western medicine
Trial: 15673175
Drug: Perspective imposed
RxNorm normalized name: black imported fire ant allergenic extract
DrugBank: Solenopsis richteri (DB11026)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perspective imposed by language (e.g., 'You are driving a car' or 'You are fueling a car')
Trial: 15673175
Drug: Actions directed
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Actions directed toward parts of the car (e.g., roof or wheels)
Trial: 11729034
Drug: Cortisol (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cortisol (15 mg)
Trial: 2203486
Drug: Intravenous RO
RxNorm normalized name: RO-5045337
DrugBank: RO-5045337 (DB14793)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous RO 42-5892 (100 micrograms/kg)
Trial: 2203486
Drug: Intravenous RO
RxNorm normalized name: RO-5045337
DrugBank: RO-5045337 (DB14793)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous RO 42-5892 (1000 micrograms/kg)
Trial: 31958667
Drug: Shared a
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Shared a lot treatment (another child shared 6 stickers)
Trial: 31958667
Drug: Shared a
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Shared a little treatment (another child shared 1 sticker)
Trial: 10562784
Drug: Ketoprofen 0.3-3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen 0.3-3.0 mg kg-1 administered pre-emptively i.v. during operation
Trial: 2110787
Drug: Intramuscular morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular morphine and hyoscine (scopolamine)
Trial: 2110787
Drug: Oral lorazepam
RxNorm normalized name: Lorazepam
DrugBank: Lorazepam (DB00186)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral lorazepam plus intramuscular morphine and hyoscine
Trial: 22836859
Drug: Low-fat diet
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat diet (<20 g of fat/d) for 4 weeks in the suggestive group
Trial: 21329887
Drug: Group 1
RxNorm normalized name: Chlamydophila psittaci biogroup 1 Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group 1 (PUUO without treatment)
Trial: 11288011
Drug: Reviparin (low-molecular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reviparin (low-molecular weight heparin) administered once daily subcutaneously for 7 to 10 days
Trial: 23230457
Drug: Intravenous nicardipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous nicardipine
Trial: 3297467
Drug: Intravenous nicardipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous nicardipine + oral captopril (50 mg)
Trial: 26860796
Drug: JianYuTangKang (JYTK)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JianYuTangKang (JYTK) plus metformin
Trial: 18467730
Drug: Current therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Current therapy
Trial: 12910567
Drug: 150 international
RxNorm normalized name: CONDOM,INTERNAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 international units of human IFN alfa administered oromucosally 3 times per day for 24 weeks
Trial: 10781467
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg spinal bupivacaine
Trial: 1485370
Drug: Intravenous oxycodone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous oxycodone (4.6-7.3 mg)
Trial: 1485370
Drug: Oral oxycodone
RxNorm normalized name: oxycodone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral oxycodone tablets (9.1 mg)
Trial: 1485370
Drug: Oral oxycodone
RxNorm normalized name: oxycodone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral oxycodone syrup (9.1 mg)
Trial: 1485370
Drug: Rectal oxycodone
RxNorm normalized name: oxycodone Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rectal oxycodone suppository (30 mg)
Trial: 2858149
Drug: Supportive therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive therapy of dynamic type or simple basal therapy
Trial: 30720931
Drug: Topical Daprodustat
RxNorm normalized name: daprodustat
DrugBank: Daprodustat (DB11682)
FDA approved: no
EMA approved: no
PMDA approved: yes
Description: Topical Daprodustat (1.0% at 100 mg/cm2 for 14 days)
Trial: 22149337
Drug: Ecallantide, a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ecallantide, a potent and specific plasma kallikrein inhibitor, administered subcutaneously.
Trial: 19156709
Drug: Antidepressants augmented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressants augmented with atypical antipsychotics (AAP) for more than 2 weeks (n = 100)
Trial: 19156709
Drug: Antidepressants only
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressants only (non‐AAP group, n = 172)
Trial: 17548728
Drug: Neopterin levels
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neopterin levels > or = 12.11 nmol/L at 4 months after ACS
Trial: 17548728
Drug: High-dose atorvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose atorvastatin among subjects with neopterin levels > or = 12.11 nmol/L at baseline
Trial: 11246058
Drug: Aspirin (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (160 mg/d)
Trial: 11246058
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of aspirin (75 mg/d) and warfarin (INR 2.0‐2.5)
Trial: 2692344
Drug: Diclofenac-Na 100
RxNorm normalized name: Diclofenac Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac-Na 100 mg
Trial: 23333095
Drug: High polyphenol
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High polyphenol olive oil (961 mg/kg)
Trial: 23333095
Drug: Moderate polyphenol
RxNorm normalized name: Pomegranate Fruit Polyphenol Extract
DrugBank: Pomegranate (DB14317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate polyphenol olive oil (289 mg/kg)
Trial: 18771406
Drug: PRO 140
RxNorm normalized name: Climara Pro
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PRO 140 2 mg/kg
Trial: 18771406
Drug: PRO 140
RxNorm normalized name: Climara Pro
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PRO 140 5 mg/kg
Trial: 8688387
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose aspirin (60 mg daily)
Trial: 30444150
Drug: SQ HDM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SQ HDM SLIT-tablet (5000, 10,000, or 20,000 JAU) for 14 days
Trial: 30444150
Drug: SQ HDM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SQ HDM SLIT-tablet (up-dosing regimen: 5,000 JAU on days 1-3, 10,000 JAU on days 4-7, 20,000 JAU on days 8-14) for 14 days
Trial: 29288190
Drug: Organ-saving treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Organ-saving treatment using short-course radiotherapy
Trial: 24707863
Drug: Oral morphine
RxNorm normalized name: morphine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral morphine sulphate (MOR)
Trial: 12646763
Drug: Intramuscular (i.m.)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (i.m.) administration of 2 mg clonazepam
Trial: 12646763
Drug: Oral (p.o.)
RxNorm normalized name: Oral Film
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral (p.o.) administration of 2 mg clonazepam
Trial: 12646763
Drug: Intravenous (i.v.)
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (i.v.) administration of 2 mg clonazepam
Trial: 8807096
Drug: Debulking chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Debulking chemotherapy (vincristine, adriamycin, and dexamethasone or methylprednisolone)
Trial: 1381611
Drug: arotinolol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: arotinolol (10 mg bid)
Trial: 27798510
Drug: Denosumab on
RxNorm normalized name: Denosumab only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab on top of standard treatment (calcium and vitamin D), n = 46
Trial: 27798510
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment alone, n = 44
Trial: 10916043
Drug: Dopamine agonists
RxNorm normalized name: Dopamine agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dopamine agonists (bromocriptine, lisuride, cabergoline, ropinirole)
Trial: 10916043
Drug: Low doses
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low doses of L-dopa (added as a second step if necessary)
Trial: 8885585
Drug: Bupropion 3
RxNorm normalized name: buPROPion 300 mg/24 hours oral tablet, extended release
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupropion 3 to 6 mg/kg per day, administered twice daily
Trial: 30241119
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment only (Control group)
Trial: 12197840
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with interferon‐α 2a/2b plus ribavirin
Trial: 6781156
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination of dihydralazin and propranolol
Trial: 6781156
Drug: Antihypertensive standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antihypertensive standard therapy
Trial: 29480916
Drug: Osteopathic Manipulative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Osteopathic Manipulative Treatment (OMT) for a maximum of 20 minutes
Trial: 29141653
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual with access to a website with PRB resources.
Trial: 19378515
Drug: 0.3 mg
RxNorm normalized name: biotin 0.3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg kg(‐1) of rocuronium (1 ED95)
Trial: 8799402
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no drug given)
Trial: 6386002
Drug: Dipyridamole (225
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipyridamole (225 mg/day) and Aspirin (975 mg/day)
Trial: 6371535
Drug: Dipyridamole and
RxNorm normalized name: Dipyridamole
DrugBank: Dipyridamole (DB00975)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dipyridamole and Aspirin
Trial: 30976908
Drug: LBW-based dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LBW-based dosing of palonosetron
Trial: 30976908
Drug: Fixed dosing
RxNorm normalized name: Humalog Mix
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed dosing of palonosetron (0.075 mg)
Trial: 22971669
Drug: Duloxetine 30
RxNorm normalized name: duloxetine 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 30 mg/d
Trial: 16970087
Drug: Yanshu Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yanshu Injection (20 ml daily)
Trial: 11227684
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy intervention during the first dressing change (Group A)
Trial: 3654132
Drug: 3 mL
RxNorm normalized name: WATER,INHL 3 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mL antiseptic soap
Trial: 28284187
Drug: RISKIT-CJS intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: RISKIT-CJS intervention in addition to treatment as usual
Trial: 16396771
Drug: ViGePP regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ViGePP regimen (gemcitabine, vinorelbine, procarbazine, and prednisone) administered every 4 weeks up to six courses.
Trial: 11531149
Drug: Insulin-meal interval
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin-meal interval of 15 min
Trial: 11531149
Drug: Insulin-meal interval
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin-meal interval of 30 min
Trial: 9280186
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (30 mg/d as amino acid chelate for 3 weeks)
Trial: 27009070
Drug: Low-dose CT
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose CT screening (T0)
Trial: 27009070
Drug: Low-dose CT
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose CT screening (T1)
Trial: 22108915
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg oral estradiol (n=6)
Trial: 22108915
Drug: 50 μg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 μg/day transdermal 17β‐estradiol (n=5)
Trial: 18028044
Drug: Morphine intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine intravenous patient-controlled analgesia (IV PCA) (1 mg morphine/dose)
Trial: 12565114
Drug: Morphine intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine intravenous patient-controlled analgesia (IV PCA)
Trial: 15704203
Drug: Denufosol (10,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denufosol (10, 20, 40, and 60 mg, administered by inhalation via the Pari LC Star nebulizer)
Trial: 15704203
Drug: Denufosol (maximum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denufosol (maximum tolerated dose)
Trial: 1702916
Drug: Pygeum africanum
RxNorm normalized name: Pygeum africanum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pygeum africanum extract (50 mg capsules, 1 capsule in the morning and 1 capsule in the evening for 60 days)
Trial: 1702916
Drug: Placebo (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (1 capsule in the morning and 1 capsule in the evening for 60 days)
Trial: 531221
Drug: 3000 microgram
RxNorm normalized name: vitamin B12
DrugBank: Cyanocobalamin Co-57 (DB09385)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3000 microgram (155)-methyl PGF2 alpha methyl ester (U-36,384) via slow release vaginal suppository
Trial: 531221
Drug: 500 microgram
RxNorm normalized name: Etizolam 500 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 microgram 16-phenoxy-omega-tetranor PGE2 methyl sulfonylamide (Sulproston) via intramuscular injection at 4 hour intervals, totaling 1250 +/- 154 microgram
Trial: 15814549
Drug: corticosteroid therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: corticosteroid therapy
Trial: 7709947
Drug: Silver-coated catheter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silver-coated catheter (5% silver oxide) in women not receiving antibiotics
Trial: 7709947
Drug: Silver-coated catheter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silver-coated catheter (5% silver oxide) in men not receiving antibiotics
Trial: 7709947
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (standard silicone elastomer-coated latex catheter) in men not receiving antibiotics
Trial: 2704247
Drug: Apomorphine (0.009
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apomorphine (0.009 mg/kg)
Trial: 29527812
Drug: Closed-incision negative
RxNorm normalized name: INCISED NOTOPTERYGIUM RHIZOME OR ROOT (NOTOPTERYGIUM FRANCHETII)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Closed-incision negative pressure therapy (ciNPT)
Trial: 24934734
Drug: Anticoagulation therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoagulation therapy alone
Trial: 17328989
Drug: Thalidomide 200
RxNorm normalized name: thalidomide 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thalidomide 200 mg daily as maintenance therapy